Prophylaxis of Venous Thromboembolism in Children: A Systematic Review

Lotte Hejberg Pedersen1, Gitte Bonde Villadsen1, Maja Hellfritzsch2

  • 1Faculty of Health, Aarhus University, Aarhus, Denmark.

Insights

Pharmacological thromboprophylaxis for pediatric venous thromboembolism (VTE) is under-researched. Evidence suggests it benefits critically ill children with multiple risk factors, without increasing bleeding risk.

Area of Science:

  • Pediatric Hematology
  • Critical Care Medicine
  • Pharmacology

Background:

  • Pediatric venous thromboembolism (VTE) is rare but serious.
  • Current VTE prophylaxis guidelines for children lack robust evidence, relying on adult data and expert opinion.

Purpose of the Study:

  • To systematically review evidence on the benefits of pharmacological thromboprophylaxis (low molecular weight heparin or unfractionated heparin) in children (≤18 years).
  • To identify specific pediatric populations that may benefit from thromboprophylaxis.

Main Methods:

  • Systematic review of studies published up to October 3, 2021, searching MEDLINE and Embase.
  • Included studies compared pharmacological thromboprophylaxis with no prophylaxis in children with radiologically verified VTE.
  • Data from 10 studies involving 976 children were analyzed across three population categories: intensive care unit (ICU), fracture/surgery, and systemic disease.

Main Results:

  • Reduced VTE incidence with thromboprophylaxis was observed in specific ICU populations (central venous catheter, mechanical ventilation; trauma with high risk) and children with acute lymphoblastic leukemia (ALL) on L-asparaginase/steroids with a central venous catheter.
  • No significant increase in bleeding risk was associated with pharmacological thromboprophylaxis.
  • VTE incidence was lower with prophylaxis in ICU patients with central venous catheter and mechanical ventilation (7/27 vs 13/24), ICU trauma patients (0/21 vs 13/96), and ALL patients (0/82 vs 8/121).

Conclusions:

  • Pharmacological thromboprophylaxis in children is sparsely investigated.
  • Evidence suggests thromboprophylaxis may benefit pediatric patients with multiple VTE risk factors, particularly in critical care settings.
  • Further research is needed to establish clear guidelines for pediatric VTE prophylaxis.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
21
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
22
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
40
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
31
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
33
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
41